Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 5/20 | 0.42 |
| ▸ | HNF4A | P41235 | 1/20 | 0.42 |
| ▸ | RARA | P10276 | 4/20 | 0.39 |
| ▸ | RARB | P10826 | 4/20 | 0.39 |
| ▸ | RARG | P13631 | 4/20 | 0.39 |
| ▸ | MAP3K14 | Q99558 | 2/20 | 0.38 |
| ▸ | CYP26A1 | O43174 | 1/20 | 0.37 |
| ▸ | CYP26B1 | Q9NR63 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.30 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.30 |
| ▸ | SSTR5 | P35346 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9009683 | 0.80 | RARA (0.34) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL8089804 | 0.79 | RXRA (0.38) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL8081756 | 0.79 | RARA (0.38) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL14376650 | 0.78 | RXRA (0.46) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL9850251 | 0.78 | RXRA (0.56) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL6668058 | 0.78 | RXRA (0.50) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL9850143 | 0.72 | RXRA (0.53) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL6668009 | 0.72 | RXRA (0.47) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL6669631 | 0.71 | MAP3K14 (0.43) | RXRAHNF4ARARARARBRARG | |
| SCHEMBL30250112 | 0.70 | LMNA (0.46) | RXRAHNF4ARARARARBRARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0740665-B1 | PROCESS FOR PREPARING 4,4-DIALKYL-6-HALO-CHROMANS OR THIOCHROMANS USEFUL AS PHARMACEUTICAL INTERMEDIATES | ALLERGAN SALES INC (US) | 2000-12-06 | — | — | EP | disclosed |
| US-5519150-A | Process for preparing 4,4-dialkyl-6-halo-chromans or thiochromans useful as pharmaceutical intermediates | ALLERGAN (US) | 1996-05-21 | — | — | US | disclosed |
| US-5420295-A | Process for preparing 4,4-dialkyl-6-halo-chromans or thiochromans useful as pharmaceutical intermediates | ALLERGAN, INC. (US) | 1995-05-30 | — | — | US | disclosed |